Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRAL: Moxifloxacin vs Amoxicillin Clavulanic Acid in AECB
NCT00656747Phase 4Completed
- Sponsor
- Bayer
- Start
- Mar 2008
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 31
01
Overview
A Phase 4 trial of moxifloxacin in chronic bronchitis (CB), sponsored by Bayer. Started Mar 2008; status: completed.
02
Drugs
moxifloxacin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00656747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656747.